Alnylam Pharmaceuticals Inc
(FRA:DUL)
€
281
+8 (+2.93%)
Market Cap: 36.70 Bil
Enterprise Value: 35.18 Bil
PE Ratio: 85.53
PB Ratio: 38.84
GF Score: 63/100 Sorry the transcript is not found. Please try another one.